DZ3055A1 - Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant. - Google Patents
Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant.Info
- Publication number
- DZ3055A1 DZ3055A1 DZ000113A DZ000113A DZ3055A1 DZ 3055 A1 DZ3055 A1 DZ 3055A1 DZ 000113 A DZ000113 A DZ 000113A DZ 000113 A DZ000113 A DZ 000113A DZ 3055 A1 DZ3055 A1 DZ 3055A1
- Authority
- DZ
- Algeria
- Prior art keywords
- polymorphs
- bicyclo
- oct
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14023399P | 1999-06-22 | 1999-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ3055A1 true DZ3055A1 (fr) | 2004-03-27 |
Family
ID=22490317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ000113A DZ3055A1 (fr) | 1999-06-22 | 2000-06-21 | Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant. |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US6262067B1 (cs) |
| EP (1) | EP1187834A1 (cs) |
| JP (1) | JP2003502425A (cs) |
| KR (1) | KR20020030280A (cs) |
| CN (1) | CN1390216A (cs) |
| AP (1) | AP2001002367A0 (cs) |
| AR (1) | AR024411A1 (cs) |
| AU (1) | AU767336B2 (cs) |
| BG (1) | BG106205A (cs) |
| BR (1) | BR0011835A (cs) |
| CA (1) | CA2375265A1 (cs) |
| CO (1) | CO5190663A1 (cs) |
| CZ (1) | CZ20014458A3 (cs) |
| DZ (1) | DZ3055A1 (cs) |
| EA (1) | EA004264B1 (cs) |
| EC (1) | ECSP003538A (cs) |
| EE (1) | EE200100698A (cs) |
| HR (1) | HRP20010920A2 (cs) |
| HU (1) | HUP0201694A3 (cs) |
| IL (1) | IL146410A0 (cs) |
| IS (1) | IS6161A (cs) |
| MA (1) | MA26744A1 (cs) |
| MX (1) | MXPA02000033A (cs) |
| NO (1) | NO20016187L (cs) |
| NZ (1) | NZ515348A (cs) |
| OA (1) | OA11952A (cs) |
| PA (1) | PA8496701A1 (cs) |
| PE (1) | PE20010322A1 (cs) |
| PL (1) | PL352899A1 (cs) |
| SK (1) | SK18672001A3 (cs) |
| TN (1) | TNSN00137A1 (cs) |
| TR (1) | TR200103688T2 (cs) |
| UY (1) | UY26211A1 (cs) |
| WO (1) | WO2000078759A1 (cs) |
| ZA (1) | ZA200110387B (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6387925B1 (en) * | 1999-06-01 | 2002-05-14 | Pfizer Inc. | Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
| US6756379B2 (en) * | 2001-07-26 | 2004-06-29 | Taro Pharmaceutical Industries Ltd. | Non-sedating barbiturate compounds as neuroprotective agents |
| US6939873B2 (en) * | 2000-07-26 | 2005-09-06 | Taro Pharmaceuticals Industries Limited | Non-sedating barbituric acid derivatives |
| US7683071B2 (en) * | 2000-07-26 | 2010-03-23 | Taro Pharmaceuticals Industries Ltd. | Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid |
| EP1551846A1 (en) * | 2002-10-04 | 2005-07-13 | Merck Sharp & Dohme Ltd. | Azabicyclic spiroether derivatives as receptor antagonists |
| WO2004052350A2 (en) | 2002-12-11 | 2004-06-24 | Taro Pharmaceutical Industries Limited | Method of treating movement disorders using barbituric acid derivatives |
| EP1781624A4 (en) * | 2004-07-02 | 2010-06-23 | Taro Pharma Ind | PROCESS FOR THE PREPARATION OF 1-METHOXYMETHYL-5,5-DIPHENYLBARBITURIC ACID |
| EP2081576A4 (en) * | 2006-11-14 | 2010-06-30 | Taro Pharmaceuticals North Ame | METHOD FOR IMPROVING BIOAVAILABILITY FOR NON-EDMING BARBITURATES |
| UA102128C2 (en) * | 2008-12-05 | 2013-06-10 | Х. Луннбек А/С | Nalmefene hydrochloride dihydrate |
| EP3976600A1 (en) * | 2019-06-03 | 2022-04-06 | Biotheryx, Inc. | Non-hygroscopic crystalline salts of a pyrazole compound, and pharmaceutical compositions and use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
| RU2103269C1 (ru) * | 1991-05-31 | 1998-01-27 | Пфайзер Инк. | Производные хинуклидина или их фармацевтически приемлемые соли и фармацевтическая композиция |
| WO1994011368A1 (en) * | 1992-11-12 | 1994-05-26 | Pfizer Inc. | Quinuclidine derivative as substance p antagonist |
| US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
-
2000
- 2000-05-04 US US09/564,528 patent/US6262067B1/en not_active Expired - Fee Related
- 2000-06-06 EA EA200101179A patent/EA004264B1/ru not_active IP Right Cessation
- 2000-06-06 AU AU47745/00A patent/AU767336B2/en not_active Ceased
- 2000-06-06 SK SK1867-2001A patent/SK18672001A3/sk unknown
- 2000-06-06 BR BR0011835-4A patent/BR0011835A/pt not_active IP Right Cessation
- 2000-06-06 HU HU0201694A patent/HUP0201694A3/hu unknown
- 2000-06-06 IL IL14641000A patent/IL146410A0/xx unknown
- 2000-06-06 WO PCT/IB2000/000756 patent/WO2000078759A1/en not_active Application Discontinuation
- 2000-06-06 MX MXPA02000033A patent/MXPA02000033A/es unknown
- 2000-06-06 HR HR20010920A patent/HRP20010920A2/hr not_active Application Discontinuation
- 2000-06-06 EE EEP200100698A patent/EE200100698A/xx unknown
- 2000-06-06 PL PL00352899A patent/PL352899A1/xx not_active Application Discontinuation
- 2000-06-06 CN CN00809305A patent/CN1390216A/zh active Pending
- 2000-06-06 TR TR2001/03688T patent/TR200103688T2/xx unknown
- 2000-06-06 CZ CZ20014458A patent/CZ20014458A3/cs unknown
- 2000-06-06 CA CA002375265A patent/CA2375265A1/en not_active Abandoned
- 2000-06-06 NZ NZ515348A patent/NZ515348A/en unknown
- 2000-06-06 KR KR1020017016407A patent/KR20020030280A/ko not_active Ceased
- 2000-06-06 JP JP2001504925A patent/JP2003502425A/ja active Pending
- 2000-06-06 EP EP00929745A patent/EP1187834A1/en not_active Withdrawn
- 2000-06-06 PA PA20008496701A patent/PA8496701A1/es unknown
- 2000-06-06 AP APAP/P/2001/002367A patent/AP2001002367A0/en unknown
- 2000-06-06 OA OA1200100314A patent/OA11952A/en unknown
- 2000-06-13 CO CO00043885A patent/CO5190663A1/es not_active Application Discontinuation
- 2000-06-20 AR ARP000103053A patent/AR024411A1/es not_active Application Discontinuation
- 2000-06-20 UY UY26211A patent/UY26211A1/es not_active Application Discontinuation
- 2000-06-20 PE PE2000000613A patent/PE20010322A1/es not_active Application Discontinuation
- 2000-06-21 MA MA26007A patent/MA26744A1/fr unknown
- 2000-06-21 TN TNTNSN00137A patent/TNSN00137A1/fr unknown
- 2000-06-21 DZ DZ000113A patent/DZ3055A1/xx active
- 2000-06-22 EC EC2000003538A patent/ECSP003538A/es unknown
-
2001
- 2001-11-13 IS IS6161A patent/IS6161A/is unknown
- 2001-12-10 BG BG106205A patent/BG106205A/bg unknown
- 2001-12-18 NO NO20016187A patent/NO20016187L/no not_active Application Discontinuation
- 2001-12-19 ZA ZA200110387A patent/ZA200110387B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2805818B1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
| FR2789079B3 (fr) | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant | |
| EE04613B1 (et) | Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim | |
| MA27392A1 (fr) | Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant | |
| DZ2594A1 (fr) | Dérivés de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant. | |
| DZ2461A1 (fr) | Dérivés d'arylkylamines nouveaux et composition pharmaceutiques les contenant. | |
| EE9900441A (et) | Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nende solvaatide suu kaudu manustamiseks | |
| FR2807038B1 (fr) | Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant | |
| DE69822209D1 (de) | ESTRON-SULFatase HEMMENDE ESTRON-SULFAMATVERBINDUNGEN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON | |
| MA26453A1 (fr) | Derives de 6-phenylpyridyl-2 amine et compositions pharmaceutiques les contenant | |
| EE04799B1 (et) | Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
| MA26968A1 (fr) | Compositions pharmaceutiques contenant du maleate d'amlodipine. | |
| HUP0302319A3 (en) | Pharmaceutical composition for oral administration of active ingredient | |
| FR2775596B1 (fr) | Nouvelles compositions pharmaceutiques | |
| MA26507A1 (fr) | Compositions pharmaceutiques d'aerosol | |
| EP1539730A4 (en) | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD FOR THEIR APPLICATION | |
| HUP0201334A3 (en) | Hydrochloride of fused-heterocycle compound and pharmaceutical compositions containing the same | |
| FR2761066B1 (fr) | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant | |
| EE200200281A (et) | Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks | |
| MA26547A1 (fr) | Composes nouveaux, antagonistes des recepteurs de vitronectine, et compositions pharmaceutiques les contenant. | |
| FR2740134B1 (fr) | Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant | |
| DZ3055A1 (fr) | Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant. | |
| FR2796380B3 (fr) | Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant | |
| HUP0000960A3 (en) | Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same | |
| FR2796940B1 (fr) | Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant |